• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to secondary sidebar

OINDPnews


Copley Scientific banner
  • Home
  • News
    • Business
    • Features
    • Medical
    • Regulatory
    • Products and Services
    • People
  • Events
  • Suppliers
    • Supplier listing and advertising options
    • Capsules and blisters
    • Consultants
    • Contract research
    • Contract manufacturing
    • Devices
    • Education
    • Excipients
      • Clinical Technology
    • Filling equipment
    • Instruments
    • Particle manufacturing
    • Software and modeling
  • Jobs
  • Resources
    • Webinars
    • White papers
  • LGWP Propellants
    • HFA 152a
    • HFO-1234ze(E)
    • LGWP Regulation
  • Contact

A Q&A with Copley’s Clair Brooks on alternative BE approaches in new FDA guidance

Can you explain the term “realistic APSD” within the context of the standard compendial test setup for APSD measurement?

This is most easily done via a direct comparison of relevant test setups, as shown below. Figure 1A shows a test setup for classic compendial APSD measurements for DPIs; Figure 1B shows a test setup that enables realistic APSD measurements.

Figure 1A – a classic test setup for APSD measurement for DPIs with NGI, standard USP/Ph.Eur. induction port, flow meter, critical flow controller, and vacuum pump

(A)

Figure 1B – a comparable test setup for realistic APSD measurement additionally incorporating breathing simulator and mixing inlet, with an Alberta Idealized Throat in place of the standard induction port

The new PSGs recommend using “mouth-throat models of different sizes (e.g. small and large)” to make realistic APSD measurements.  In the image of the classic setup (1A), you see a standard, right-angled USP/Ph. Eur. induction port which is known to underpredict deposition in the mouth-throat, a potentially confounding limitation when it comes to demonstrating BE. You see a more clinically representative induction port in the setup for realistic APSD (1B); in this case, the port is the Alberta Idealized Throat.

In addition to using a more representative interface between the device and the impactor, the realistic APSD setup uses a breathing simulator in accordance with the regulatory guidance for realistic APSD measurement to apply “breathing profiles (e.g. weak and strong) that are representative of the entire patient population.” In contrast to the compendial methods for orally inhaled products, which specify constant flow rates for APSD measurement in which the applied profile is a sharp-edged square wave, a breathing simulator allows the application of far more clinically representative test conditions via the adjustment of variables such as rate of acceleration to peak flow.

Share
« Previous Page 1 2 3 4Next page »

published on October 10, 2024

Primary Sidebar

Sign up for our free weekly newsletter

Upcoming Events
Sponsored by Intertek

Want information about upcoming OINDP-related events delivered directly to your inbox? click here

  • June 17-June 18: Rescon Europe 2025, Paris, France
  • June 19-June 20: Metered Dose Inhaler (MDI) Technology Training Course, online
  • June 22-June 25: ISAM Congress 2025, Washington, DC, USA
  • June 25-June 25: SMI.London 2025, London, UK
  • September 18-September 19: IPAC-RS Nasal Innovation Forum, West Trenton, NJ, USA
  • See all upcoming events

    Secondary Sidebar

    Suppliers

    Capsules and blisters
    Consultants
    Contract research
    Contract manufacturing
    Devices
    Education
    Excipients
    Filling equipment
    Instruments
    Particle manufacturing
    Software and modeling
    Merxin We Make Inhalers banner
    © 2025 OINDPnews